Frédérique Spyratos
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology top 5%
- Genetics top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- K. HacèneM. Tubiana-HulinRosette LidereauJacques RouësséCatherine AndrieuIvan BiècheMartine TrassardA Desplaces
- Topics
- Breast Cancer Treatment Studies (12 papers)Estrogen and related hormone effects (11 papers)HER2/EGFR in Cancer Research (11 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Frédérique Spyratos
41 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 878
- Cancer Research 788
- Oncology 660
- Genetics 280
- Pulmonary and Respiratory Medicine 204
Countries citing papers authored by Frédérique Spyratos
This map shows the geographic impact of Frédérique Spyratos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Spyratos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Spyratos more than expected).
Fields of papers citing papers by Frédérique Spyratos
This network shows the impact of papers produced by Frédérique Spyratos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Spyratos. The network helps show where Frédérique Spyratos may publish in the future.
Co-authorship network of co-authors of Frédérique Spyratos
This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Spyratos. A scholar is included among the top collaborators of Frédérique Spyratos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Spyratos. Frédérique Spyratos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 97 | |
| 2 | 58 | |
| 3 | 40 | |
| 4 | 79 | |
| 5 | 55 | |
| 6 | 93 | |
| 7 | Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial. | 17 |
| 8 | 52 | |
| 9 | 26 | |
| 10 | 23 | |
| 11 | 152 | |
| 12 | 15 | |
| 13 | 17 | |
| 14 | 9 | |
| 15 | 10 | |
| 16 | 25 | |
| 17 | 34 | |
| 18 | 47 | |
| 19 | 9 | |
| 20 | 48 |
About Frédérique Spyratos
Frédérique Spyratos is a scholar working on Cancer Research, Oncology and Genetics, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (11 papers) and HER2/EGFR in Cancer Research (11 papers). The work is most often cited by research in Cancer Research (788 citations), Oncology (660 citations) and Immunology and Allergy (127 citations). Frédérique Spyratos has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include K. Hacène, M. Tubiana-Hulin, Rosette Lidereau, Jacques Rouëssé, Catherine Andrieu, Ivan Bièche, Martine Trassard, A Desplaces, M Brunet and M. Ferrero-Poüs. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.